Jun Liu
Novo Nordisk Postdoctoral Research Fellow
I studied clinical medicine at Shanghai Jiao Tong University, China, graduating in 2013. I then undertook a one-year research training placement on the clinical epidemiology of type 2 diabetes at the Department of Endocrine and Metabolic Diseases in Rui-Jin Hospital, Shanghai. After I obtained my MSc degree in genetic epidemiology at Erasmus Medical Center in Rotterdam, Netherlands, I continued as a scientific researcher and was awarded my PhD degree (thesis title: Integration of Multi-Omics in Type 2 Diabetes and Related Disorders Research). In 2019, I moved to Oxford and joined the Nuffield Department of Population Health (NDPH), University of Oxford, for my first postdoctoral position. I continued working on implementing novel analytic approaches to high-dimensional analysis, and during this time I used UK Biobank data to integrate multi-omics in cardiometabolic diseases and related neurological disorders.
From September 2021, I started my Novo Nordisk Research Fellowship working with Professor Cornelia van Duijn (NDPH) and Dr Joanna Howson (Novo Nordisk Research Centre Oxford) on a project entitled, "An Integrative Cross-omics Study of Non-Alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis".
Recent publications
-
Novel genetic insights into the roles of amino acids in metabolic dysfunction-associated steatotic liver disease
Preprint
Liu J. et al, (2024)
-
Genome-wide characterization of circulating metabolic biomarkers.
Journal article
Karjalainen MK. et al, (2024), Nature
-
Profiling the genome and proteome of metabolic dysfunction-associated steatotic liver disease identifies potential therapeutic targets.
Journal article
Liu J. et al, (2023), medRxiv
-
A Type 1 Diabetes Polygenic Score Is Not Associated With Prevalent Type 2 Diabetes in Large Population Studies.
Journal article
Srinivasan S. et al, (2023), J Endocr Soc, 7
-
Circulating inflammatory cytokines and female reproductive diseases: a Mendelian randomization analysis.
Journal article
Lin Y. et al, (2023), J Clin Endocrinol Metab